Ilika advancing Goliath product development with placings (LON:IKA)

Ilika plc

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss their successful institutional & retail placings, what the fund will be used for, total share allocation, deadline, and the excess application facility.

Q1: First off, congratulations on Ilika’s successful institutional and retail placings, I think your secured £21 million. Steve, what is the principal use of the funds?

A1: There’s three principle uses of the funds.

£10 million of the proceeds of the placing are expected to be used to fund the development of our large scale battery technology which is for a consumer appliance and electric vehicle applications, which we’ve codenamed Goliath. That’s to take it beyond conventional lithium-ion battery performance.

£5 million is expected to be invested in increasing the capacity of our Goliath pre-pilot line that we have here in Romsey, taking it from 1 kilowatt hour to 10 kilowatt hours, and that’s largely through increased automation of our processes.

Then the balance is to strengthen our balance sheet and provide additional working capital to support the Goliath product development.

Q2: How have you allowed retail investors to participate in the placing?

A2: So, retail investors have been able to participate through a £3 million retail offer by Primary Bid that actually closed on Friday last week, but also through a £3.7 million open offer. The circular for this was posted out to existing shareholders yesterday but it’s also available as a download from the investor section of our website.

Q3: What determined the total share allocation then in the placing for retail investors?

A3: So, the total of £6.7 million that we’ve made available to retail investors through the retail and open offers is the maximum that the company can offer without the need to issue a prospectus. That would have involved considerable extra costs and delays to the fundraising process, which is why we’ve elected to go this route.

Q4: When is the deadline for participating in the open offer?

A4: The deadline for the receipt of the completed application form along with payment is 11:00am on the 27th of July.

Q5: Now, do the open offer mentions a one to 52 entitlement? What happens if a retail investor would like to purchase more than they’re entitled in the placing?

A5: So, applications by shareholders will be satisfied in full up to their open offer entitlement so that 1 in 52, but shareholders can apply for more than that 1 in 52 through the excess application facility. So, if all of the open offer entitlements are not taken up by shareholders, Ilika will allocate shares up to the maximum 3.7 million allowed so those shareholders who’ve applied through this excess application facility.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search